Lung cancer remains the leading cause of cancer death worldwide. According to the World Health Organization, lung cancer was responsible for 1.8 million deaths — 18% of cancer deaths — in 2020 alone.
Viatris’ broad portfolio of both off-patent and new, innovative medicines address many NCDs such as cardiovascular disease, diabetes, respiratory diseases, dermatology and ophthalmology.
We have taken a deliberate approach to expand access to our wide portfolio across geographies and income levels, where we seek to build and establish sustainable markets by nurturing innovation and competition.
Aflac, working with sports broadcaster, fashion entrepreneur and cancer survivor Erin Andrews, today launched Check for Cancer, a national movement aimed at boosting U.S. cancer screening rates by 10% over the next decade.
Aflac employee Cyronn Herrington had a unique childhood, starting at birth. He was diagnosed with hemophilia B, a chronic bleeding disorder that keeps blood from clotting properly.
The company opened a clinical physiology lab near the Five Points neighborhood of Denver, Colorado, to conduct its clinical trials not only with a wide array of participants but with more speed and frequency, leading to faster innovation.
In Colombia, the fight against disease outbreaks is reaching a critical point—and the collaboration between Direct Relief and FedEx is helping make a tangible difference.
If you’re taking a GLP-1 hormone medication like Ozempic, Wegovy, Victoza, or Mounjaro (or a compounded version), you already know its positive effects. Decreasing your appetite, calming cravings, reducing “food noise,” and helping you feel full.
In August 2023, Medtronic LABS and Virtua launched Healthy Neighbor. The goal was to improve health outcomes through a home healthcare program for patients living with high blood pressure and/or type 2 diabetes. And it’s working.
Jeff Simmons, President and CEO of Elanco Animal Health, recently joined the Bloomberg Businessweek Daily to discuss the company's strategic framework and detail why he sees sustainable value creation continuing for years to come.
PATH has launched a groundbreaking initiative to address the rising burden of hemoglobinopathies—particularly Thalassemia—in India, with the support of a grant from the Bristol Myers Squibb Foundation (BMS Foundation). The program aims to strengthen local health systems.
Trane Technologies is a global climate innovator with a clear purpose to boldly challenge what’s possible for a sustainable world. See how embedding...
AEG embraces its responsibility to enrich the lives of people in the communities around the world where we do business, and to use business to create...
In states where Key has a presence, there are approximately 1.7 million low- to moderate-income (LMI) households. Many LMI individuals don’t have bank...
